Subscribe
Advertisement
  • Subscribe To The Enterprise
  • Contact Us
Subscribe For $2.50/Month
Print Editions
The Enterprise
  • News
    • Local
    • Sports
    • Business
    • Education
    • Family
    • Community Calendar
    • Neighborhood News
    • State News
    • National News
  • Obituaries
  • Spiritual
    • Southern Baptist
    • Parabola
    • Transcendental Meditation
    • The Episcopal Diocese of Virginia
  • eEnterprise
  • Legals
  • Contact
  • Account
  • Login
  • FAQ
No Result
View All Result
  • News
    • Local
    • Sports
    • Business
    • Education
    • Family
    • Community Calendar
    • Neighborhood News
    • State News
    • National News
  • Obituaries
  • Spiritual
    • Southern Baptist
    • Parabola
    • Transcendental Meditation
    • The Episcopal Diocese of Virginia
  • eEnterprise
  • Legals
  • Contact
  • Account
  • Login
  • FAQ
No Result
View All Result
The Enterprise
No Result
View All Result

Research Advancing in Virginia with $3.3 Million ‘Catalyst’ Awards

Enterprise by Enterprise
November 25, 2019
in Opinions
0
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Virginia Catalyst, a non-profit corporation,  awarded $3.3 million in grants to six innovative life science and bioscience collaborations, according to Gov. Ralph Northam.

The six collaborations are designed to address major unmet healthcare needs and drive economic growth in Virginia, according to a release from Northam.

The grants fund projects that:

Have the potential to significantly improve human health and create high-value jobs,

Accelerate the commercialization of inventions and discoveries at Virginia universities, and

Strengthen Virginia’s competitive advantage in life sciences research.

“As a pediatric neurologist, I recognize that better treatments for cancer start with advancements in life science research,” said Northam. “Virginia Catalyst is driving this progress, strengthening scientific collaboration and enabling the Commonwealth to compete on a national scale. Virginia has deployed $70 million in grants that leveraged another $650 million in follow-on funding to accelerate science and technology-based research, development, and commercialization.”

This is Virginia Catalyst’s 10th round of funding. It has awarded 43 grants totaling $20 million, resulting in over $34 million in matching funds and an additional $163 million in follow-on funding since 2013.

Virginia Catalyst, formerly known as Virginia Biosciences Health Research Corporation (VBHRC), is funded by the General Assembly, the University of Virginia, Virginia Commonwealth University, Virginia Tech, Eastern Virginia Medical School, George Mason University, Old Dominion University, and William & Mary.

“This grant program requires ‘skin in the game,’ because award recipients must find industry partners willing to invest matching funds for their projects,” said Mike Grisham, CEO of Virginia Catalyst. “This brings investment capital here to finance commercialization of Virginia’s innovations. It’s all about advancing life science and creating high-paying jobs across the Commonwealth.”

Grants were awarded to the following projects:

Microsystem for label-free separation and recovery of tumor-associated cells from biopsies for precision medicine

Company: CytoRecovery, Inc. (Blacksburg)

Collaborators: Virginia Tech and University of Virginia

Amount: $400,000

 

Commercializing a novel treatment for metastatic cancers

Company: InterLeukin Combinatorial Therapies, Inc. (Richmond)

Collaborators: Virginia Commonwealth University and University of Virginia

Amount: $700,000

 

Design & Implement of green, enzymatic biofungicides for pre- & post-harvest crop protection

Company: Lytos Technologies, LLC (Charlottesville)

Collaborators: University of Virginia and Virginia Tech

Amount: $500,000

 

Protein painting of PD-1/PD-L1 for the discovery of new immune checkpoint inhibitors for the treatment of lung cancer and brain metastasis

Company: Monet Pharmaceuticals (Nokesville)

Collaborators: George Mason University and Virginia Tech

Amount: $400,000

 

Automated 3D spinal navigation system for bedside lumbar puncture procedures

Company: RIVANNA (Charlottesville)

Collaborators: University of Virginia and Virginia Commonwealth University

Amount: $800,000

 

Development of an applicator & training simulator for a gel patch for nonsurgical eardrum repair

Company: Tympanogen (Richmond)

Collaborators: Eastern Virginia Medical School and Virginia Commonwealth University

Amount: $500,000

 

Sign up for our free newsletter

Enter your email address to join our weekly newsletter.

You will receive a confirmation email for your subscription. Please check your inbox and spam folder to complete the confirmation process.
Some fields are missing or incorrect!
Lists
Previous Post

Baby Names Reflect Demographic Shifts

Next Post

Read to Me Day at PSP Held

Next Post
Read to Me Day at PSP Held

Read to Me Day at PSP Held

Subscribe To Our Newsletter

Sign up now to get weekly top stories, eEdition notifications, deals and more from The Enterprise right to your inbox.
  • Subscribe
  • Contact The Enterprise
  • eEnterprise
  • My Account

  • Login
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
No Result
View All Result
  • News
    • Local
    • Sports
    • Business
    • Education
    • Family
    • Community Calendar
    • Neighborhood News
    • State News
    • National News
  • Obituaries
  • Spiritual
    • Southern Baptist
    • Parabola
    • Transcendental Meditation
    • The Episcopal Diocese of Virginia
  • eEnterprise
  • Legals
  • Contact
  • Account
  • Login
  • FAQ